Add BrightSurf on Google Email

BMJ Group


Marketing claims for infant formula should be banned, argue experts

Marketing experts argue that current regulations do not effectively prevent potentially misleading claims about infant formula, which may carry health risks for vulnerable populations. The proposed solution includes premarket approval for changes to formula composition and higher scientific substantiation standards for claims.

SourceBMJ Group·JournalThe BMJ·DateMay 6, 2020